- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05413889
Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model
December 28, 2023 updated by: Wake Forest University Health Sciences
Validation and Implementation Design of a Pragmatic Randomized Controlled Trial Leveraging Epic Systems 30-day Unplanned Readmission Risk Model
The objective is to assess the implementation of a computerized clinical decision support (cCDS) tool for identifying patients at high risk of unplanned readmission who could benefit from existing care programs aimed at reducing readmissions
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Providers from either service, which includes attending physicians, residents, hospitalists, and advanced practice providers (APPs), will be randomly allocated to an intervention group (IG) or control group (CG).
The IG will consist of placing the Epic 30-day unplanned readmission risk score in the story board of providers.
If a patient is identified as having a high risk of readmission defined as readmission risk >20%, a link to transitional and supportive care services (TSC) will be appear in the story board.
Providers will determine which TSC is best for the patient and may order whichever TSC is appropriate for the patient.
The study team will not recommend TSCs.
The risk of readmission score will be present from the time of admission for those in the IG.
The CG will have the same TSC orders available to them; however, they will not have the risk of readmission score present in their workflow, as such the embedded link to TSC will also not be present.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients of Atrium Health Wake Forest Baptist Hospital (AHWFBH)
- 18 years or older
- meeting inpatient criteria
- admitted to hospitalist or general medicine teaching services
- Providers on the hospitalist or general medicine teaching services
Exclusion Criteria:
- Psychiatric diagnoses during index or subsequent admission
- left Against Medical Advice (AMA)
- planned readmission
- died during index admission
- Providers who opt out of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention group (IG)
The IG will consist of placing the Epic 30-day unplanned readmission risk score in the story board of providers - If a patient is identified as having a high risk of readmission defined as readmission risk >20%, a link to transitional and supportive care services (TSC) will be appear in the story board
|
If a patient is identified as having a high risk of readmission defined as readmission risk >20%, a link to transitional and supportive care services (TSC) will be appear in the story board.
|
No Intervention: control group (CG)
The CG will have the same transitional and supportive care services (TSC) orders available to them; however, they will not have the risk of readmission score present in their workflow
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Faith Health
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Faith Health
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - High Risk Readmission Program (HRI)
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - High Risk Readmission Program (HRI)
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Care Plus
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Care Plus
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Population Health Pharmacy
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Population Health Pharmacy
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Geriatrics Transitional Care
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Geriatrics Transitional Care
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Mobile Health Clinic
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Mobile Health Clinic
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Faith Health
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Faith Health
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group- High Risk Readmission Program (HRI)
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - High Risk Readmission Program (HRI)
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Care Plus
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Care Plus
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Population Health Pharmacy
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Population Health Pharmacy
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Geriatrics Transitional Care
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Geriatrics Transitional Care
|
Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Mobile Health Clinic
Time Frame: Day 30
|
Number of transitional and supportive care services (TSC) referrals by providers in the Intervention group - Mobile Health Clinic
|
Day 30
|
Provider Satisfaction Score
Time Frame: Day 30
|
Provider satisfaction with clinical decision support tool measured by survey
|
Day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
30 day Readmission Rate
Time Frame: Day 30
|
proportion of index inpatient visits with an inpatient readmission within 30 days of index discharge
|
Day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Donna Williams, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2023
Primary Completion (Actual)
August 15, 2023
Study Completion (Actual)
August 17, 2023
Study Registration Dates
First Submitted
June 6, 2022
First Submitted That Met QC Criteria
June 8, 2022
First Posted (Actual)
June 10, 2022
Study Record Updates
Last Update Posted (Actual)
December 29, 2023
Last Update Submitted That Met QC Criteria
December 28, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- IRB00079395
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Study protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR)
IPD Sharing Time Frame
Data will be available beginning 3 months and ending 5 years following article publication
IPD Sharing Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unplanned Hospital Readmissions
-
University of South FloridaPatient-Centered Outcomes Research Institute; AdventHealth; Tampa General Hospital and other collaboratorsNot yet recruitingHospital Readmissions
-
University of California, San FranciscoGordon and Betty Moore FoundationCompletedHospital ReadmissionsUnited States
-
Hospices Civils de LyonUnknownTrend in Hospital Lengths of Stay and ReadmissionsFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHospital Readmissions of Elderly PatientsFrance
-
Planned Parenthood League of MassachusettsSociety of Family PlanningCompletedPregnancy, UnplannedUnited States
-
University of ChicagoCompletedUnplanned PregnancyUnited States
-
BayerCompleted
-
University of North Carolina, Chapel HillCompletedUnplanned PregnancyUnited States
-
University of California, San FranciscoCompleted
-
Sintetica SACross Research S.A.TerminatedUnplanned Caesarean SectionBelgium
Clinical Trials on Epic 30-day unplanned readmission risk score
-
NYU Langone HealthCompletedCOVID | Corona Virus Infection | Adverse EventUnited States
-
Luzerner KantonsspitalUniversity of LucerneCompletedHospital ReadmissionSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Indiana UniversityRecruitingMetastatic CancerUnited States
-
University of SienaMerck Sharp & Dohme LLCUnknownSkin Diseases | Pneumonia | Bacteremia | Urinary Tract Infections | Enterobacteriaceae InfectionsItaly
-
St. Jude Children's Research HospitalIncyte Corporation; Amgen; ServierActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic LymphomaUnited States, Australia